A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223

European Heart Journal

Volumn 37, Issue 33, 2016, Pages 2602a-2611a

  Wang, Kun ^a   Long, Bo ^b   Liu, Fang ^c   Wang, Jian Xun ^a   Liu, Cui Yun ^a   Zhao, Bing ^a   Zhou, Lu Yu ^a   Sun, Teng ^a   Wang, Man ^a   Yu, Tao ^a   Gong, Ying ^a   Liu, Jia ^a   Dong, Yan Han ^a   Li, Na ^a   Li, Pei Feng ^a  

^a QINGDAO UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac hypertrophy; Circular RNA; Heart failure; HRCR

Indexed keywords

APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN; CIRCULAR RNA; MICRORNA 223; RNA; UNCLASSIFIED DRUG; MICRORNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CARDIOMEGALY; TRANSGENIC MOUSE;

ANIMALS; CARDIOMEGALY; HEART FAILURE; MICE; MICE, TRANSGENIC; MICRORNAS; MYOCYTES, CARDIAC;

EID: 84987657380     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv713     Document Type: Article

References (47)

1. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-228.
2. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002;415:206-212.
3. Everett AD, Tufro-McReddie A, Fisher A, Gomez RA. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 1994;23:587-592.
4. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7:589-600.
5. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature 2013;495: 384-388.
6. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013;495:333-338.
7. Zhang Y, Zhang X-O, Chen T, Xiang J-F, Yin Q-F, Xing Y-H, Zhu S, Yang L, Chen L-L. Circular intronic long noncoding RNAs. Mol Cell 2013;51:792-806.
8. Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. Circular RNAs are abundant, conserved, and associated with alu repeats. RNA 2013;19:141-157.
9. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN. The nuclear RNAse III drosha initiates microRNA processing. Nature 2003;425:415-419.
10. Ohtani K, Dimmeler S. Control of cardiovascular differentiation by microRNAs. Basic Res Cardiol 2011;106:5-11.
11. Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 2011;208: 549-560.
12. Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, Fan GC. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 2010;122: 1308-1318.
13. Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, Abdellatif M. MicroRNA-21 is a downstream effector of Akt that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 2010;285:20281-20290.
14. Li P. MicroRNAs in cardiac apoptosis. J Cardiovasc Transl Res 2010;3:219-224.
15. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, DornGW II, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613-618.
16. Wang J, Song Y, Zhang Y, Xiao H, Sun Q, Hou N, Guo S, Wang Y, Fan K, Zhan D, Zha L, Cao Y, Li Z, Cheng X, Zhang Y, Yang X. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 2012;22: 516-527.
17. Verma SK, Krishnamurthy P, Barefield D, Singh N, Gupta R, Lambers E, Thal M, Mackie A, Hoxha E, Ramirez V, Qin G, Sadayappan S, Ghosh AK, Kishore R. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappab. Circulation 2012;126: 418-429.
18. Kashihara T, Nakada T, Shimojo H, Horiuchi-Hirose M, Gomi S, Shibazaki T, Sheng X, Hirose M, Hongo M, Yamada M. Chronic receptor-mediated activation of gi/o proteins alters basal t-tubular and sarcolemmal l-type ca(2)(+) channel activity through phosphatases in heart failure. Am J Physiol Heart Circ Physiol 2012;302: H1645-H1654.
19. Li YZ, Lu DY, Tan WQ, Wang JX, Li PF. P53 initiates apoptosis by transcriptionally targeting the anti-apoptotic protein Arc. Mol Cell Biol 2008;28:564-574.
20. Koseki T, Inohara N, Chen S, Nunez G. Arc, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA 1998;95:5156-5160.
21. Donath S, Li P, Willenbockel C, Al-Saadi N, Gross V, Willnow T, Bader M, Martin U, Bauersachs J, Wollert KC, Dietz R, von Harsdorf R. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 2006;113:1203-1212.
22. Murtaza I, Wang HX, Feng X, Alenina N, Bader M, Prabhakar BS, Li PF. Downregulation of catalase and oxidative modification of protein kinase ck2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy. J Biol Chem 2008;283:5996-6004.
23. Zaiman AL, Damico R, Thoms-Chesley A, Files DC, Kesari P, Johnston L, Swaim M, Mozammel S, Myers AC, Halushka M, El-Haddad H, Shimoda LA, Peng CF, Hassoun PM, Champion HC, Kitsis RN, Crow MT. A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertension. Circulation 2011;124:2533-2542.
24. Choi WY, Giraldez AJ, Schier AF. Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430. Science 2007;318:271-274.
25. Capel B, Swain A, Nicolis S, Hacker A, Walter M, Koopman P, Goodfellow P, Lovell-Badge R. Circular transcripts of the testis-determining gene sry in adult mouse testis. Cell 1993;73:1019-1030.
26. Cocquerelle C, Mascrez B, Hetuin D, Bailleul B. Mis-splicing yields circular RNA molecules. FASEB J 1993;7:155-160.
27. Nigro JM, Cho KR, Fearon ER, Kern SE, Ruppert JM, Oliner JD, Kinzler KW, Vogelstein B. Scrambled exons. Cell 1991;64:607-613.
28. Zaphiropoulos PG. Exon skipping and circular RNA formation in transcripts of the human cytochrome p-450 2c18 gene in epidermis and of the rat androgen binding protein gene in testis. Mol Cell Biol 1997;17:2985-2993.
29. Patrucco E, Domes K, Sbroggio M, Blaich A, Schlossmann J, Desch M, Rybalkin SD, Beavo JA, Lukowski R, Hofmann F. Roles of cGMP-dependent protein kinase I (CGKI) and pde5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis. Proc Natl Acad Sci USA 2014;111:12925-12929.
30. Wang R, Wang Y, Lin WK, Zhang Y, LiuW, Huang K, TerrarDA, Solaro RJ, Wang X, Ke Y, Lei M. Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide. PLoS One 2014;9:e101974.
31. Lopez-Andres N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Diez J. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. Am J Physiol Heart Circ Physiol 2011;301: H2372-H2382.
32. Hahn NE, Musters RJ, Fritz JM, Pagano PJ, Vonk AB, Paulus WJ, van Rossum AC, Meischl C, Niessen HW, Krijnen PA. Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of h9c2 cells. Cell Signal 2014;26: 1818-1824.
33. Sakai S, Shimojo N, Kimura T, Tajiri K, Maruyama H, Homma S, Kuga K, Mizutani T, Aonuma K, Miyauchi T. Involvement of peptidyl-prolyl isomerase pin1 in the inhibitory effect of fluvastatin on endothelin-1-induced cardiomyocyte hypertrophy. Life Sci 2014;102:98-104.
34. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008;455:64-71.
35. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005;433:769-773.
36. Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res 2011;39:6845-6853.
37. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006;38:228-233.
38. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007;100:416-424.
39. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007;13:486-491.
40. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets HAND2 during cardiogenesis. Nature 2005;436:214-220.
41. Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE, Abdellatif M, Feldman DS, Elton TS, Gyorke S. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting pp2a regulatory subunit b56alpha and causing CaMKII-dependent hyperphosphorylation of RYR2. Circ Res 2009;104:514-521.
42. Xu M, Wu HD, Li RC, Zhang HB, Wang M, Tao J, Feng XH, Guo YB, Li SF, Lai ST, Zhou P, Li LL, Yang HQ, Luo GZ, Bai Y, Xi JJ, GaoW, Han QD, Zhang YY, Wang XJ, Meng X, Wang SQ. miR-24 regulates junctophilin-2 expression in cardiomyocytes. Circ Res 2012;111:837-841.
43. Xu XD, Song XW, Li Q, Wang GK, Jing Q, Qin YW. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol 2012;227:1391-1398.
44. Gurha P, Wang T, Larimore AH, Sassi Y, Abreu-Goodger C, Ramirez MO, Reddy AK, Engelhardt S, Taffet GE, Wehrens XH, Entman ML, Rodriguez A. MicroRNA-22 promotes heart failure through coordinate suppression of PPAR/ ERR-nuclear hormone receptor transcription. PLoS One 2013;8:e75882.
45. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD, Camargo FD. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008;451: 1125-1129.
46. SunW, ShenW, Yang S, Hu F, Li H, Zhu TH. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta. Cell Res 2010;20:1158-1169.
47. Yuan JY, Wang F, Yu J, Yang GH, Liu XL, Zhang JW. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of k562 cells. J Cell Mol Med 2009;13:4551-4559.